Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.
Data will appear here once earnings are reported.

OTCQXZCOR
All numbers in thousands USD
Period Ending
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Net Income
(46,640)
(95,454)
(69,359)
(90,632)
Operating Activities, Cash Flows Provided By or Used In
Depreciation
13,576
4,193
5,062
4,118
Changes In Accounts Receivables
(22,241)
(4,254)
(2,793)
(728)
Changes In Assets and Liabilities
8,739
(217)
3,936
1,711
Changes In Inventories
24,789
429
(1,525)
137
Changes In Other Operating Activities
10,813
40,489
(485)
12,527
Total Cash Flow From Operating Activities
(10,964)
(54,814)
(65,164)
(72,867)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures
(40)
(9)
(88)
(7,237)
Investments
4,997
55,218
(17,496)
56,102
Other Cash flows from Investing Activities
13
0
(400)
0
Total Cash Flows From Investing Activities
4,970
55,209
(17,984)
48,865
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid
--
--
--
--
Sale/Purchase of Stock
0
5,228
32,888
272
Net Borrowings
2,935
(1,316)
36,465
21,375
Other Cash Flows from Financing Activities
(2,021)
0
0
0
Total Cash Flows From Financing Activities
914
3,912
69,353
21,647
Effect Of Exchange Rate Changes
(2)
(74)
530
45
Change In Cash and Cash Equivalents
(5,080)
4,307
(13,795)
(2,355)

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2020 Zyla Life Sciences
All rights reserved.